Perkins Capital Management »

Shimmick Corporation shares owned by Perkins Capital Management

Quarter-by-quarter ownership of Shimmick Corporation (SHIM) shares owned by Perkins Capital Management from 13F filings

Historical chart of Perkins Capital Management investment in Shimmick Corporation

Tip: Access up to 7 years of quarterly data

All positions including Shimmick Corporation held by Perkins Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Shimmick Corporation by Perkins Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $299k 52k 5.76
2023-12-31 $343k 52k 6.60

More positions owned by Perkins Capital Management

Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Augmedix (AUGX)
IDEXX Laboratories (IDXX)
Natera (NTRA)
Advanced Micro Devices (AMD)
Quicklogic Corp Com New (QUIK)
Neogenomics Com New (NEO)
Abbott Laboratories (ABT)
Veracyte (VCYT)
Alphatec Hldgs Com New (ATEC)
Elutia Cl A Com (ELUT)
Axogen (AXGN)
Inuvo Com New (INUV)
LeMaitre Vascular (LMAT)

View all positions for Perkins Capital Management

Top funds holding Shimmick Corporation

Sanders Morris Harris
Pacific Ridge Capital Partners
Bnp Paribas Investment Partners
1492 Capital Management
Gilder, Gagnon, Howe & Co
Citadel Advisors
American Century Companies
Perkins Capital Management
Geode Capital Management
Millennium Management
Perritt Capital Management
Citigroup
Bank of America Corporation
Qube Research & Technologies
Jpmorgan Chase & Co

View all funds holding Shimmick Corporation